Stakeholder-informed pragmatic trial protocol of the TabCAT-BHA for the detection of cognitive impairment in primary care
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Background: Cognitive impairment and dementia are frequently under-recognized. Health system strategies anchored in primary care are essential to address gaps in timely, comprehensive diagnosis. The goal of this paper is to describe the adaptation of a tablet-based brain health assessment (TabCAT-BHA) intervention and the study protocol to test its effectiveness in improving the detection of cognitive impairment, including dementia. Methods: This mixed-methods, pragmatic, cluster randomized, hybrid effectiveness-implementation trial is being conducted in two 18-month waves with 26 Kaiser Permanente Southern California primary care clinics, with 13 serving as intervention clinics and 13 as usual care clinics. Patients 65 years and older with memory concerns (n ~ 180,000) receiving care at the 26 clinics will be included in the analyses. Primary care clinics are provided the following practice supports as part of the TabCAT-BHA intervention: brief education and training on neurocognitive disorders and study workflows; digital tools to assess cognitive function and support clinician decision making and documentation; and registered nurse support during the work-up and post-diagnosis periods for primary care providers, patients, and families. The intervention was adapted based on engagement with multiple levels of clinical and operational leaders in the healthcare system. Effectiveness outcomes include rates of cognitive impairment diagnosis in primary care and rates of completed standardized cognitive assessments and specialist referrals with incident diagnoses. Implementation outcomes include acceptability-appropriateness-feasibility, adoption, and fidelity. Results: We identified seven themes organized by system-, provider-, and patient-level domains that were used to adapt the TabCAT-BHA intervention. Accordingly, changes were made to the provider education, diagnostic work-up, and post-diagnostic support. Results will be reported in fall of 2027. Conclusions: Our engagement with multiple primary and specialty care clinical and operational leaders to adapt the TabCAT-BHA intervention to these primary care clinics has informed the protocol to evaluate the intervention’s effectiveness for improving the detection of cognitive impairment, including dementia, in an integrated healthcare system. Trial Registation: Clinicaltrials.gov: NCT06090578 (registered 10/24/23).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“LLMs can serve as collaborative partners that help clinicians interpret familiar clinical information (e.g., neuroimaging, laboratory results, and clinical notes) by incorporating the latest evidence-based information and highlighting subtle patterns that might be overlooked in busy clinical settings.45–47”
From Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias (2026) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living
Lawton, M. P., & Brody, E. M. (1969) · The Gerontologist · doi:10.1093/geront/9.3_part_1.179 · Cited by 18,540
Proctor, E., Silmere, H., Raghavan, R., Hovmand, P., Aarons, G., Bunger, A., Griffey, R., & Hensley, M. (2011) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-010-0319-7 · Cited by 8,721 · cited 1×
“Implementation outcomes follow the Proctor et al. [26] framework (Table 1 and Supplemental Table 1) and include: (1) Acceptability, Appropriateness, and Feasibility: Primary and specialty care stakeholders will be satisfied with the intervention and its fit to their practices based on their pre-and…”
BackgroundLecanemab in early Alzheimer's disease
van Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212948 · Cited by 5,678 · cited 1×
“[29, 30] The intervention relies on PCPs to be alert to and formally identify patient-and family-raised memory concerns as the initiating step in the protocol.”
BackgroundProgress in Development of the Index of ADL
Katz, S., Downs, T. D., Cash, H. R., & Grotz, R. C. (1970) · The Gerontologist · doi:10.1093/geront/10.1_part_1.20 · Cited by 4,118 · cited 1×
“The RN then follows up with the family or friend via phone within a week to complete a functional assessment [24, 25] and triangulates the findings with the TabCAT-BHA results and chart review to arrive at a preliminary classification of mild or major neurocognitive disorder (MCI or dementia).”
MethodDonanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
Sims, J. R., Zimmer, J. A., Evans, C. D., Lu, M., Ardayfio, P., Sparks, J., Wessels, A. M., Shcherbinin, S., Wang, H., Monkul Nery, E. S., et al. (2023) · JAMA · doi:10.1001/jama.2023.13239 · Cited by 2,932
The PRECIS-2 tool: designing trials that are fit for purpose
Loudon, K., Treweek, S., Sullivan, F., Donnan, P., Thorpe, K. E., & Zwarenstein, M. (2015) · BMJ · doi:10.1136/bmj.h2147 · Cited by 1,846 · cited 1×
“Consistent with pragmatic trial principles, [22, 23] all patients seen at least once across the 26 clinics will be included and the primary analyses will use data extracted from the EMR.”
MethodTunis (2003) · doi:10.1001/jama.290.12.1624 · Cited by 1,724 · cited 1×
“Consistent with pragmatic trial principles, [22, 23] all patients seen at least once across the 26 clinics will be included and the primary analyses will use data extracted from the EMR.”
MethodMissed and Delayed Diagnosis of Dementia in Primary Care: Prevalence and Contributing Factors
Bradford, A., Kunik, M. E., Schulz, P., Williams, S. P., & Singh, H. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181a6bebc · Cited by 969
Davis, A. C., Voelkel, J. L., Remmers, C. L., Adams, J. L., & McGlynn, E. A. (2023) · The Permanente Journal · doi:10.7812/tpp/22.172 · Cited by 402 · cited 1×
“[19] The 26 primary care clinics have a median of 18 providers and median panel size of 2054, serving over 180,000 patients 65 years and older (Blacks/African-Americans: 20%, Hispanics/Latinos: 35%, Asians/Pacific Islanders: 14%).”
Backgroundthe EVIDEM-ED project, Koch, T., & Iliffe, S. (2010) · BMC Family Practice · doi:10.1186/1471-2296-11-52 · Cited by 275 · cited 1×
“[3–5] Studies of the Medicare annual wellness visit, which requires detection of CI if present, have found inconsistent effects on detection, [6, 7] and very few published studies address other ways to improve detection of CI in primary care.”
BackgroundOptimal multivariate matching before randomization
Greevy, R. (2004) · Biostatistics · doi:10.1093/biostatistics/5.2.263 · Cited by 205 · cited 1×
“[20, 21] Matching variables included number of providers, median panel size, percentage of members self-identified as Black/African American, Hispanic/Latino or Asian/Pacific Islander, baseline rate of CI diagnoses, rates of telehealth encounters, and percentage of members who were 65 + in the…”
BackgroundTsoy, E., Kiekhofer, R. E., Guterman, E. L., Tee, B. L., Windon, C. C., Dorsman, K. A., Lanata, S. C., Rabinovici, G. D., Miller, B. L., Kind, A. J. H., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.0399 · Cited by 182
Self-citationPrimary Care Physicians’ Perceived Barriers to Optimal Dementia Care: A Systematic Review
Mansfield, E., Noble, N., Sanson-Fisher, R., Mazza, D., & Bryant, J. (2019) · The Gerontologist · doi:10.1093/geront/gny067 · Cited by 143 · cited 1×
“[3–5] Studies of the Medicare annual wellness visit, which requires detection of CI if present, have found inconsistent effects on detection, [6, 7] and very few published studies address other ways to improve detection of CI in primary care.”
BackgroundThe Brain Health Assessment for Detecting and Diagnosing Neurocognitive Disorders
Possin, K. L., Moskowitz, T., Erlhoff, S. J., Rogers, K. M., Johnson, E. T., Steele, N. Z. R., Higgins, J. J., Stiver, J., Alioto, A. G., Farias, S. T., et al. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15208 · Cited by 136 · cited 1×
“[14–16] Previous pilot work implementing an earlier version of this intervention found that streamlining workflow and providing EMR-integrated guidance were crucial for acceptability and adoption.”
MethodSelf-citationFactors associated with cognitive evaluations in the United States
Kotagal, V., Langa, K. M., Plassman, B. L., Fisher, G. G., Giordani, B. J., Wallace, R. B., Burke, J. R., Steffens, D. C., Kabeto, M., Albin, R. L., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001096 · Cited by 119 · cited 1×
“[1, 2] Health system strategies, especially efficient, scalable, and sustainable practice support models anchored in primary care, are essential to address gaps in timely, comprehensive diagnosis.”
BackgroundPrimary Care Practitioner Perspectives on the Role of Primary Care in Dementia Diagnosis and Care
Sideman, A. B., Ma, M. J., de Jesús, A. H., Alagappan, C., Razon, N., Dohan, D. P., Chodos, A. H., Al‐Rousan, T., Alving, L. I., Segal‐Gidan, F., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.36030 · Cited by 107
Self-citationDevelopment and Validation of eRADAR: A Tool Using EHR Data to Detect Unrecognized Dementia
Barnes, D. E., Zhou, J., Walker, R. L., Larson, E. B., Lee, S. J., Boscardin, W. J., Marcum, Z. A., & Dublin, S. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16182 · Cited by 96
Agile Implementation: A Blueprint for Implementing Evidence‐Based Healthcare Solutions
Boustani, M., Alder, C. A., & Solid, C. A. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15283 · Cited by 85 · cited 1×
“[17, 27] It also requires careful coordination with intersecting specialties (geriatrics, neurology, and psychiatry), and leaders of other related initiatives to improve dementia diagnosis and care for alignment and consistent messaging.”
BackgroundJacobson, M., Thunell, J. A., & Zissimopoulos, J. (2020) · Health Affairs · doi:10.1377/hlthaff.2019.01795 · Cited by 83 · cited 1×
“[3–5] Studies of the Medicare annual wellness visit, which requires detection of CI if present, have found inconsistent effects on detection, [6, 7] and very few published studies address other ways to improve detection of CI in primary care.”
BackgroundFowler, N. R., Perkins, A. J., Gao, S., Sachs, G. A., & Boustani, M. A. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16247 · Cited by 79 · cited 1×
“[8–12] The need is particularly acute among underserved populations for whom incomplete and delayed diagnosis are more prevalent.”
BackgroundFowler, N. R., Campbell, N. L., Pohl, G. M., Munsie, L. M., Kirson, N. Y., Desai, U., Trieschman, E. J., Meiselbach, M. K., Andrews, J. S., & Boustani, M. A. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15330 · Cited by 51 · cited 1×
“[3–5] Studies of the Medicare annual wellness visit, which requires detection of CI if present, have found inconsistent effects on detection, [6, 7] and very few published studies address other ways to improve detection of CI in primary care.”
BackgroundA Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults
Rodriguez‐Salgado, A. M., Llibre‐Guerra, J. J., Tsoy, E., Peñalver, A. I., Bringas, G., Erlhoff, S. J., Kramer, J. H., Allen, I. E., Valcour, V., Miller, B. L., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200985 · Cited by 45
Self-citationBHA-CS: A novel cognitive composite for Alzheimer's disease and related disorders
Tsoy, E., Erlhoff, S. J., Goode, C. A., Dorsman, K. A., Kanjanapong, S., Lindbergh, C. A., La Joie, R., Strom, A., Rabinovici, G. D., Lanata, S. C., et al. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12042 · Cited by 38
Self-citationReweighted Mahalanobis distance matching for cluster‐randomized trials with missing data
Greevy, R. A., Grijalva, C. G., Roumie, C. L., Beck, C., Hung, A. M., Murff, H. J., Liu, X., & Griffin, M. R. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3260 · Cited by 32 · cited 1×
“[20, 21] Matching variables included number of providers, median panel size, percentage of members self-identified as Black/African American, Hispanic/Latino or Asian/Pacific Islander, baseline rate of CI diagnoses, rates of telehealth encounters, and percentage of members who were 65 + in the…”
BackgroundColey, R. Y., Smith, J. J., Karliner, L., Idu, A., Lee, S. J., Fuller, S., Lam, R., Barnes, D. E., & Dublin, S. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07736-6 · Cited by 30 · cited 1×
“We explored other opportunities to identify patients at high risk for having undetected CI using validated algorithms, [31, 32] and sending pre-visit queries about their memory.”
BackgroundNguyen, H. Q., Borson, S., Khang, P., Langer‐Gould, A., Wang, S. E., Carrol, J., & Lee, J. S. (2022) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12279 · Cited by 29 · cited 1×
“[18] The TabCAT-BHA trial is being conducted in two 18-month waves with 26 Kaiser Permanente Southern California (KPSC) primary care clinics that serve a highly diverse patient population in the greater Los Angeles area (Fig.”
MethodSelf-citationLessons from Detecting Cognitive Impairment Including Dementia (DetectCID) in Primary Care
Sideman, A. B., Chalmer, R., Ayers, E. I., Gershon, R. C., Verghese, J., Wolf, M. S., Ansari, A., Arvanitis, M., Bui, N. M., Chen, P., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215106 · Cited by 27
Self-citationDublin, S., Greenwood-Hickman, M. A., Karliner, L., Hsu, C. W., Coley, R. Y., Colemon, L., Carrasco, A., King, D., Grace, A., Lee, S. J., et al. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107356 · Cited by 14 · cited 1×
“[8–12] The need is particularly acute among underserved populations for whom incomplete and delayed diagnosis are more prevalent.”
BackgroundChalmer, R., Ayers, E. I., Weiss, E. F., Malik, R., Ehrlich, A., Wang, C., Zwerling, J. L., Ansari, A., Possin, K. L., & Verghese, J. (2022) · Neurodegenerative Disease Management · doi:10.2217/nmt-2021-0043 · Cited by 12
Self-citationKleiman, M. J., Plewes, A. D., Owora, A. H., Grout, R. W., Dexter, P. R., Fowler, N. R., Galvin, J. E., Miled, Z. B., & Boustani, M. A. (2022) · Trials · doi:10.1186/s13063-022-06809-5 · Cited by 12
Linden, I., Wolfs, C., Perry, M., Metsemakers, J., van der Weijden, T., de Vugt, M. D., Verhey, F., Handels, R., Rikkert, M. O., Dirksen, C., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049322 · Cited by 8
Research works printed but not linked: 1
- Goodrich D, Miake-Lye I, Braganza M, Wawrin N, Kilbourne A. Quality Enhancement Research Initiative. QUERI Roadmap for Implementation and Quality Improvement. 2020. https://www.queri.research.va.gov/tools/roadmap/ 33400452
Cited by
Enhancing early detection of cognitive impairment in primary care with the TabCAT-BHA
Breithaupt, A. G., Sideman, A. B., Goode, C., Hill‐Sakurai, L., Premkumar, M., Scheffler, A. W., Chodos, A., Tsoy, E., Rankin, K. P., Kramer, J. H., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70437 · Cited by 10
Self-citationReview of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias
Breithaupt, A. G., Tang, A., Paolillo, E. W., Bibars, M., Johnson, E. C. B., Saloner, R., Possin, K. L., Windon, C. C., Hill-Jarrett, T. G., Giorgio, J., et al. (2026) · Seminars in Neurology · doi:10.1055/a-2744-9871 · Cited by 6
Self-citationPeruvian validation and standardization of the TabCAT-brain health assessment
Pacheco, A. O. M.-N., Montemurro, M., Tejada, M. D. C., Rivera-Fernández, C., Sánchez-Fernández, M., Custodio, N., Possin, K. L., Tsoy, E., Lanata, S., & Soto‐Añari, M. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1600131 · Cited by 3
Self-citationUsing Digital Tools for Cognitive Assessment Across Levels of Care
Singh, S. M., & Weisenbach, S. L. (2026) · Springer eBooks · doi:10.1007/978-3-032-22457-6_10
Metadata
- Authors
- Sideman, A. B., Nguyen, H. Q., Langer-Gould, A., Lee, E. A., Borson, S., Shen, E., Tsoy, E., Macias, M., Goode, C., Rankin, K., Kramer, J., & Possin, K. L.
- Affiliations
- University of California, San Francisco (US)
- Kaiser Permanente (US)
- Los Angeles Medical Center (US)
- Corresponding author
- Nguyen, Huong Q.
- ORCID
- Venue
- BMC Primary Care
- Published
- 2024-08-06
- Volume
- 25
- Issue
- 1
- Pages
- 286-286
- ISSN
- 1471-2296 (ISSN-L)
- 2731-4553
- PMC
- PMC11302096
- OpenAlex
- W4401367665
- Cited by
- 4
- References
- 31
- Citations by year
- 2026: 1 · 2025: 3
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Family Practice (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Neurological Disorders and Stroke (U01NS128913)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- cognitive impairment detection, dementia, primary care, older adults, stakeholder engagement, intervention adaptation, clinician education and training, practice support, Kaiser Permanente, hybrid effectiveness-implementation trial
- MeSH terms
- Stakeholder Participation, Aged, California, Dementia, Female, Humans, Primary Health Care, Computers, Handheld, Cognitive Dysfunction, Pragmatic Clinical Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

